Yes, ARIKAYCE (amlexanox oral granules) is FDA approved. It was approved in 2020 for the treatment of oral mucositis in adults undergoing chemotherapy for hematologic malignancies.
ARIKAYCE is a prescription medication that is available as oral granules. It works by reducing inflammation in the mouth.
Here are some key points about ARIKAYCE:
- Approved for: Oral mucositis in adults undergoing chemotherapy for hematologic malignancies.
- Mechanism of action: Reduces inflammation in the mouth.
- Dosage: Administered as oral granules.
- Availability: Prescription medication.
- Approval date: 2020.
Note: ARIKAYCE is not approved for any other use, and it is important to speak with your doctor about the risks and benefits of this medication.
